Somatostatin analogues
Showing 1 - 25 of 579
Pancreatic Diseases Trial in Rochester (Somatostatin analog)
Enrolling by invitation
- Pancreatic Diseases
- Somatostatin analog
-
Rochester, MinnesotaMayo Clinic in Rochester
Apr 21, 2022
Gastroenteropancreatic Neuroendocrine Tumor Trial in Belgium, Netherlands (Somatostatin analog)
Not yet recruiting
- Gastroenteropancreatic Neuroendocrine Tumor
- Somatostatin analog
-
Brasschaat, Antwerp, Belgium
- +19 more
Jan 31, 2023
Relapsing GH Pituitary Adenomas After Surgery
Recruiting
- Acromegaly
-
Strasbourg, FranceService Médecine Interne, Endocrinologie et Nutrition - Hôpitaux
Nov 24, 2021
PFS and OS of Advanced Neuroendocrine Cancer After Systemic
Recruiting
- Neuroendocrine Tumors
-
Olsztyn, Warmińsko-Mazurskie, Poland
- +1 more
May 12, 2021
Somatostatin Analogues in Gastroenteropancreatic Neuroendocrine
Completed
- Gastroenteropancreatic Neuroendocrine Tumours
-
Lund, Sweden
- +1 more
Jun 1, 2020
Factors Associated With Significant MYoCArdian Uptake on
Not yet recruiting
- Oncologic Disorders
- (no location specified)
Jul 26, 2022
Neuroendocrine Tumors Trial in Belgium (Liquid biopsies, Scans (CT, gallium-68 DOTATE/TOC/NOC PET-CT))
Recruiting
- Neuroendocrine Tumors
- Liquid biopsies
- Scans (CT, gallium-68 DOTATE/TOC/NOC PET-CT)
-
Bornem, Antwerp, Belgium
- +7 more
Jun 1, 2022
Neuroendocrine Tumors Trial in Edegem, Sint-Niklaas, Nicosia (Liquid biopsies, Scans (CT, gallium-68 DOTATE/TOC/NOC PET-CT))
Recruiting
- Neuroendocrine Tumors
- Liquid biopsies
- Scans (CT, gallium-68 DOTATE/TOC/NOC PET-CT)
-
Edegem, Antwerp, Belgium
- +2 more
Feb 24, 2022
Acromegaly Trial in France, Switzerland (Lanreotide (Autogel formulation))
Completed
- Acromegaly
- Lanreotide (Autogel formulation)
-
Amiens, France
- +16 more
Mar 30, 2020
Hybrid PET/MR and PET/CT in Neuroendocrine Diseases and Tumor
Recruiting
- PET / CT
- +3 more
- 68Ga-DOTA-TATE PET/MR and PET/CT imaging
-
Wuhan, Hubei, ChinaChina, Hubei Province
Apr 26, 2022
Pancreatic Neuroendocrine Tumor Trial in Milano (peptide receptor radionuclide therapy with Y-90-DOTATOC)
Recruiting
- Pancreatic Neuroendocrine Tumor
- peptide receptor radionuclide therapy with Y-90-DOTATOC
-
Milano, Italy
- +1 more
Sep 30, 2022
Meningioma Trial in Basel (177Lu-DOTA-JR11 (Phase 0); Cycle 1 and Cycle 2 (cross-over), 177Lu-DOTATOC (Phase 0); Cycle 1 and
Recruiting
- Meningioma
- 177Lu-DOTA-JR11 (Phase 0); Cycle 1 and Cycle 2 (cross-over)
- +2 more
-
Basel, Basel-Stadt, SwitzerlandUniversity Hospital Basel, Department of Neurosurgery
Aug 2, 2021
Pituitary Tumours Trial in Göteborg (Gallium-68 DOTATOC PET)
Terminated
- Pituitary Tumours
- Gallium-68 DOTATOC PET
-
Göteborg, SwedenCenter of Endocrinology and Metabolism, Sahlgrenska university H
Mar 15, 2022
High Grade Glioma, Meningioma, Embryonal Tumor Trial in United States (LUTATHERA® (Lutetium Lu 177 dotatate))
Recruiting
- High Grade Glioma
- +12 more
- LUTATHERA® (Lutetium Lu 177 dotatate)
-
Aurora, Colorado
- +8 more
Jan 16, 2023
Somatostatin Receptors and GH Receptor Expression on Bone of
Completed
- Evaluation of the Expression of Somatostatin Receptors and GH Receptor on Bone of Acromegalic Patients
- Trans-sphenoidal surgery
-
Roma, ItalyFondazione Policlinnico Gemelli IRCCS
Apr 6, 2023
Neuroendocrine Tumors, Carcinoid Tumors, Neuroblastoma Trial in Iowa City (68Ga-DOTATOC PET/CT)
Completed
- Neuroendocrine Tumors
- +3 more
- 68Ga-DOTATOC PET/CT
-
Iowa City, IowaUniversity of Iowa Health Care
Jul 24, 2021
Acromegaly Trial in Novara (Usual clinical practice + hypoproteic diet)
Not yet recruiting
- Acromegaly
- Usual clinical practice + hypoproteic diet
-
Novara, Italy: Italy Pediatric Endocrine Service of AOU Maggiore della Carità
Mar 26, 2022
Acromegaly: A Pattern of Treatment and Comparative Effectiveness
Recruiting
- Acromegaly
- Transnasal butterfly surgery
- +2 more
-
Guangzhou, Guangdong, ChinaChina Acromegaly Organization
Mar 14, 2022
Fatigue and Quality of Life in Neuroendocrine Neoplasia
Unknown status
- Neuroendocrine Tumors (NET) Health Related Qualito of Life (HRQoL)
- Somatostatin analog
-
Aarhus, DenmarkGitte Dam
Sep 14, 2020
Neuroendocrine Tumors, Liver Metastases Trial in London (TheraSpheres Selective Internal Radiation Therapy (SIRT))
Recruiting
- Neuroendocrine Tumors
- Liver Metastases
- TheraSpheres Selective Internal Radiation Therapy (SIRT)
-
London, United KingdomImperial College NHS Trust
Mar 8, 2022